Prescriptive Authority Sample Clauses

The Prescriptive Authority clause defines who is legally permitted to prescribe medications or treatments within the scope of an agreement or policy. Typically, this clause specifies that only licensed healthcare professionals, such as physicians, nurse practitioners, or physician assistants, may issue prescriptions, and may outline any limitations or requirements for such authority. By clearly establishing who holds prescriptive rights, the clause ensures compliance with applicable laws and regulations, reduces liability, and prevents unauthorized or inappropriate prescribing.
POPULAR SAMPLE Copied 1 times
Prescriptive Authority. Indicate below those drugs and/or devices the physician assistant is delegated to prescribe. 1. Medical Devices? Yes No
View SourceView Similar (3)
Prescriptive Authority. In this section, indicate the categories of drugs and/or devices which may be prescribed by the APRN including any limitations to these categories. Check the box that applies to your practice. 🞏 All drug categories or therapeutic devices may be prescribed as listed in the following formulary or reference: (list reference here) 🞏 All drug categories or therapeutic devices may be prescribed as listed in the following formulary or reference: (list reference here) With the following exceptions: 🞏 Prescriptive authority extends to the following list of drug categories: Please make a complete list, or attach a list of drug categories to this agreement. (NOTE: when making a list of drug categories on your own, be sure to make the list complete using a list that is accepted and known in your practice. It is important to not inadvertently exclude a category with a drug in it that you will be prescribing. If you do attempt to make your own list and there are omissions, the prescriptions that you write in this omitted category will not be legal.)
View SourceView Similar (2)
Prescriptive Authority. If the service provided is pharmacist assessment and prescribing according to the Regulatory Bylaws of the Saskatchewan College of Pharmacy Professionals, the patient assessment fees shall be: (i) $6.00 for Continuing Existing Prescriptions (Bylaw Part K Section 5(1)(2)): Patient requires interim supplies because remaining supplies will not be sufficient until the date of his/her next appointment with a practitioner; (ii) $6.00 for Continuing Existing Prescriptions (Bylaw Part K Section 5 (3)(4)): Patient is unable to access his/her supplies due to distance or other reasons; (iii) $10.00 for Continuing Existing Prescriptions (Bylaw Part K Section 5 (5)(6)(7)(8)): Patient is in an emergency situation and requires supplies until he/she can consult a practitioner; (iv) $6.00 for Insufficient Information (Bylaw Part K Section 6 (1)(2)): Pharmacist may alter missing information in order to dispense the drug; (v) $6.00 for Increasing Suitability of Drug (Bylaw Part K Section 7 (1)(2)): Pharmacist may alter a dosage form if more beneficial for the patient; (vi) $25.00 for Drug Reconciliation (Bylaw Part K Section 8 (1)(2)): Pharmacist may prescribe a drug to a patient recently discharged if the patient has not obtained a continuing prescription while in hospital, licensed special care home or personal care home. Pharmacist may prescribe a drug if the patient has been admitted to a hospital, licensed special care home or personal care home and the pharmacist determines the patient should receive the drug.
View SourceView Similar (2)
Prescriptive Authority. If the primary supervising physician delegates the prescribing of
View Source
Prescriptive Authority. The following quality assurance provisions regarding prescriptions shall be implemented: APRN may prescribe all drugs and therapeutic devices within his/her knowledge and skill, consistent with his/her education, clinical experience, and specialty area not excluded by and consistent with the Formulary and in accordance with the provisions of ORC §4723.481, Section 4723-9-10 of the Ohio Administrative Code, and such other rules as may be from time to time adopted by the Ohio Board of Nursing, unless otherwise restricted by an exhibit to this SCA. This shall include the ability to prescribe Schedule II controlled substances pursuant to APRN’s prescriptive authority under ORC §4723.481(C) and Section 4723-9-10 of the Ohio Administrative Code and according to Ohio law. APRN may prescribe any/all Schedule II controlled substances not excluded by the Formulary, within the scope of APRN’s practice. No Schedule II controlled substances shall be personally furnished to any patient. The APRN may prescribe all newly approved drugs and therapeutic devices or those approved for new indications by the Food and Drug Administration (“FDA”), and reviewed by the Committee on Prescriptive Governance (“CPG”), subsequent to either the date of the initial execution or the most recent review of this SCA, provided that such prescription is not excluded on the Formulary and follows this SCA and is consistent with the APRN’s scope of practice and the practice specialty of the collaborating Physician(s). The collaborating Physician(s) agree that APRN may also prescribe newly FDA-approved drugs not yet reviewed and approved by the CPG (unless later disapproved by the CPG) if the drug type or subtype is not excluded on the Formulary and is one that may be prescribed in accordance with this SCA, as referenced in Exhibit C or Exhibit C-1 Formulary.
View Source

Related to Prescriptive Authority

  • Committee Authority The Committee shall have all discretion, power, and authority to interpret the Plan and this Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith. All actions taken and all interpretations and determinations made by the Committee in good faith shall be final and binding upon the Employee, the Company and all other interested persons, and shall be given the maximum deference permitted by law. No member of the Committee shall be personally liable for any action, determination or interpretation made in good faith with respect to the Plan or this Agreement.

  • Authority Each party represents that it is authorized to bind to the terms of this DPA, including confidentiality and destruction of Student Data and any portion thereof contained therein, all related or associated institutions, individuals, employees or contractors who may have access to the Student Data and/or any portion thereof.

  • Corporate Authority; Approval Parent and each of the Merger Subs have all requisite corporate power and authority and each has taken all corporate action necessary in order to execute, deliver and perform its obligations under the Transaction Documents to which it is or is contemplated to be a party and to consummate the Transactions to which it is or is contemplated to be a party, subject to obtaining (a) the approval of the issuance of Parent Common Stock comprising the Merger Consideration (the “Stock Issuance”) by the holders of a majority of the shares of Parent Common Stock represented in person or by proxy at a meeting duly called and held for such purpose (the “Parent Requisite Vote”) and (b) the approval contemplated by Section 5.17 of this Agreement in the case of the Merger Subs. This Agreement has been duly executed and delivered by Parent and the Merger Subs and constitutes a valid and binding agreement of Parent and the Merger Subs, enforceable against each of Parent and the Merger Subs in accordance with its terms, subject to the Bankruptcy and Equity Exception. Upon execution and delivery by Parent and each of the Merger Subs of each other Transaction Document to which it is or is contemplated to be a party, each other Transaction Document to which it is or is contemplated to be a party will constitute a valid and binding agreement of Parent or the applicable Merger Sub, as applicable, enforceable against Parent or the applicable Merger Sub, as applicable, in accordance with its terms, subject to the Bankruptcy and Equity Exception. The shares of Parent Common Stock comprising the Merger Consideration have been duly authorized and, when issued pursuant to this Agreement, will be validly issued, fully paid and nonassessable, and no stockholder of Parent will have any preemptive right of subscription or purchase in respect thereof. As of the date of this Agreement, the Board of Directors of Parent has (x) (i) unanimously determined that the Transactions are fair to, and in the best interests of, Parent and its stockholders, (ii) approved the Mergers and the other Transactions, including the Stock Issuance, (iii) approved and declared advisable this Agreement and (iv) subject to Section 5.03, resolved to recommend the Stock Issuance to the holders of shares of Parent Common Stock (the “Parent Recommendation”), and (v) directed that the Stock Issuance be submitted to the holders of shares of Parent Common Stock for their approval.

  • Requisite Authority The Company has all necessary power and authority to enter into this Agreement and to perform the transactions contemplated hereby, except to the extent that the enforceability of the indemnity and/or contribution provisions contained in Section 7 of this Agreement may be limited under applicable securities laws and to the extent that the enforceability of this Agreement may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws that affect creditors’ rights generally or by equitable principles relating to the availability of remedies.

  • Corporate Authority; No Conflicts The execution, delivery and performance by such Credit Party of this Amendment and all documents, instruments and agreements contemplated herein are within such Credit Party’s corporate or other organizational powers, have been duly authorized by all necessary action, require no action by or in respect of, or filing with, any court or agency of government and do not violate or constitute a default under any provision of any applicable law or other agreements binding upon such Credit Party or result in the creation or imposition of any Lien upon any of the assets of such Credit Party except for Liens permitted under Section 7.02 of the Credit Agreement.